Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Rose 8.64% From Its 52-Week Low, But YTD Numbers Fell -13.70%. Here’s What You Need To Know At This Time
During the recent session, Biomarin Pharmaceutical Inc. (NASDAQ:BMRN)’s traded shares were 4.98 million, with the beta value of the company hitting 0.31. At the last